Cargando…

At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention

SIMPLE SUMMARY: Immunoproteasome plays a key role in the generation of antigenic peptides. Immune checkpoints therapy is a front-line treatment of advanced/metastatic tumors, and to improve its efficacy, a broader knowledge of the dynamics of antigen repertoire processing by cancer cells is mandator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tundo, Grazia R., Sbardella, Diego, Oddone, Francesco, Kudriaeva, Anna A., Lacal, Pedro M., Belogurov, Alexey A., Graziani, Grazia, Marini, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507813/ https://www.ncbi.nlm.nih.gov/pubmed/34638337 http://dx.doi.org/10.3390/cancers13194852

Ejemplares similares

The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
por: Tundo, G.R., et al.
Publicado: (2020)

Dexamethasone Downregulates Autophagy through Accelerated Turn-Over of the Ulk-1 Complex in a Trabecular Meshwork Cells Strain: Insights on Steroid-Induced Glaucoma Pathogenesis
por: Sbardella, Diego, et al.
Publicado: (2021)

The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design
por: Tundo, Grazia Raffaella, et al.
Publicado: (2023)

Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma
por: Ceci, Claudia, et al.
Publicado: (2020)

Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug
por: Tundo, Grazia Raffaella, et al.
Publicado: (2022)

A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose
por: Sbardella, Diego, et al.
Publicado: (2022)

Somatostatin Modulates Insulin-Degrading-Enzyme Metabolism: Implications for the Regulation of Microglia Activity in AD
por: Tundo, Grazia, et al.
Publicado: (2012)

Neuropilin-1 as Therapeutic Target for Malignant Melanoma
por: Graziani, Grazia, et al.
Publicado: (2015)

The Function of Immunoproteasomes—An Immunologists’ Perspective
por: van den Eshof, Bart L., et al.
Publicado: (2021)

Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution
por: Sbardella, Diego, et al.
Publicado: (2015)

Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models
por: Ceci, Claudia, et al.
Publicado: (2020)

Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
por: Kalaora, Shelly, et al.
Publicado: (2020)

Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
por: Lisi, Lucia, et al.
Publicado: (2020)

Staying on the Cutting Edge
por: Stash, Bryce D., et al.
Publicado: (2021)

Cutting edge : starter.
por: Redston, Chris
Publicado: (2002)

Cutting edge : starter.
por: Moor, Peter
Publicado: (2002)

Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors
por: Besse, Andrej, et al.
Publicado: (2022)

Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives
por: Gan, Ting, et al.
Publicado: (2020)

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1
por: Ruffini, Federica, et al.
Publicado: (2017)

Computational analysis and modeling of cleavage by the immunoproteasome and the constitutive proteasome
por: Diez-Rivero, Carmen M, et al.
Publicado: (2010)

The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor
por: Atzori, Maria Grazia, et al.
Publicado: (2022)

Cutting edge : starter. Students' book
por: Cunningham, Sarah
Publicado: (2002)

Regulation of Immunoproteasome Function in the Lung
por: Keller, Ilona E., et al.
Publicado: (2015)

Dysfunctional immunoproteasomes in autoinflammatory diseases
por: Arimochi, Hideki, et al.
Publicado: (2016)

On the Role of the Immunoproteasome in Protein Homeostasis
por: Basler, Michael, et al.
Publicado: (2021)

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
por: Ceci, Claudia, et al.
Publicado: (2018)

A Novel Mechanism of Immunoproteasome Regulation via miR-369-3p in Intestinal Inflammatory Response
por: Scalavino, Viviana, et al.
Publicado: (2022)

The best in cutting edge typography
Publicado: (1994)

The Cutting Edge: Research Update
Publicado: (2007)

The cutting edge of archaeal transcription
por: Fouqueau, Thomas, et al.
Publicado: (2018)

Commentary: Strength at the cutting edge
por: Wan, Song, et al.
Publicado: (2020)

Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
por: Gioia, Magda, et al.
Publicado: (2020)

Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
por: Franzese, Ornella, et al.
Publicado: (2022)

Corneal Wound Healing Is Compromised by Immunoproteasome Deficiency
por: Ferrington, Deborah A., et al.
Publicado: (2013)

Mobile ad hoc networking: the cutting edge directions
por: Basagni, Stefano, et al.
Publicado: (2013)

Immunoproteasome Function in Normal and Malignant Hematopoiesis
por: Tubío-Santamaría, Nuria, et al.
Publicado: (2021)

Immunoproteasome inhibition attenuates experimental psoriasis
por: del Rio Oliva, Marta, et al.
Publicado: (2022)

Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma
por: Ruffini, Federica, et al.
Publicado: (2015)

Denervation-Induced Activation of the Standard Proteasome and Immunoproteasome
por: Liu, Haiming M., et al.
Publicado: (2016)

Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
por: Atzori, Maria Grazia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uj7anfekmvh8jnpr3l5o5nggfe